The reduction in ERα expression observed in adjacent mammary gland and mammary tumors of DMBA-treated animals was consistent with previous reports of reduced ERα in familial BRCA-1 tumors [25, 26], and sporadic breast cancers with hypermethylated BRCA-1 [28]. The gene discussed is ESR1; the disease is breast cancer.